Navigation Links
CUREXO Technology Corporation Names Brent D. Mittelstadt as President & CEO

SACRAMENTO, Calif., Jan. 15 /PRNewswire/ -- CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC(R) Surgical System, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.

Mr. Mittelstadt began research in surgical robotics in 1986 as a visiting research scientist at the IBM T.J. Watson Research Center and is responsible for much of the early development of CT guided robotic systems for joint replacement surgery. In 1990, with initial investment from IBM, Mr. Mittelstadt co-founded Integrated Surgical Systems (ISS) to develop a surgical robot system to assist with hip and knee replacement surgery. In 2007, ISS with the approval of its shareholders transferred all of its assets to CUREXO Technology Corporation.

While at ISS, Mr. Mittelstadt served as Director of Surgical Applications, where he led the development and refinement of both the early pin based hip application, as well as the DigiMatch(TM) ROBODOC(R) Surgical System for Total Hip Arthroplasty (THA), which received U.S. Food and Drug Administration (FDA) clearance in August, 2008.

After leaving ISS in June 2002, Mr. Mittelstadt took a position at Consensus Orthopedics (formerly Hayes Medical Inc.), where he was Director of Marketing. Mr. Mittelstadt was part of a "turn around" management team that was integral in transforming the company. When Mr. Mittelstadt first jointed Consensus Orthopedics, it was suffering from declining sales and a poor reputation in the market. Today, Consensus Orthopedics is achieving over 60% annual growth in revenue. While at Consensus Orthopedics, Mr. Mittelstadt was involved in the development of new implants and line extensions as well as re- designing the total knee instrumentation system to address changes in the joint replacement market.

Mr. Mittelstadt received a B.S. in Biology from the University of Arizona in 1984. He holds 8 patents and has published extensively in the field of Computer Assisted Orthopedic Surgery.

"We are very excited to have Mr. Mittelstadt as a member of our senior management team. The unique combination of his ROBODOC knowledge and our recent FDA clearance provides Mr. Mittelstadt an immense opportunity to lead the company into the next phase of commercializing our products into the U.S. market. Mr. Mittelstadt brings his vast robotic experience along with integrity and vision to the company," stated Mr. Taehoon Kim, Chairman of CUREXO Technology Corporation.

About CUREXO Technology Corporation

CUREXO Technology Corporation, develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC(R) Surgical System includes two components; ORTHODOC(R), a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC(R) Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The DigiMatch(TM) ROBODOC(R) Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only computer- controlled robotic system cleared by the FDA for orthopedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC(R), ORTHODOC(R), and DigiMatch(TM) are registered trademarks of CUREXO Technology Corporation. For more information, visit


     Ms. Sheila Shah
     Marketing Communications
     CUREXO Technology Corporation
     916 285 9943 X 510

SOURCE CUREXO Technology Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Healthcare Providers Choosing IVANS High-Speed Technology to Succeed Within Medicare Modernization Era
2. PFCD Experts Cite Health Information Technology as Key Investment for Economic Stimulus
3. Versus Technology, Inc. Announces Successful Implementation of Automatic Hospital Tracking System at Anne Arundel Medical Center
4. InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
5. MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherence Programs
6. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
7. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
8. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
9. Interactive Report Maps Landscape of Technology for the Aging
10. Press Ganey Acquires PatientFlow Technology
11. Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy
Post Your Comments:
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. This is one of Joplin's most famous and beautiful concert posters. The concert ... Michigan in Ann Arbor. The According to Hawley, "It is hard to believe that ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/26/2015)... 26, 2015 ... adds "Global Repaglinide Industry 2015 ... on China Repaglinide Market, 2010-2019" reports ... and information to its online business ... . --> ...
Breaking Medicine Technology: